Skip to main navigation Skip to search Skip to main content

The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change

  • Eric Nehl*
  • , Stacy Heilman
  • , David Ku
  • , David Gottfried
  • , Sarah Farmer
  • , Robert Mannino
  • , Erika Tyburski
  • , Julie Sullivan
  • , Allison Suessmith
  • , Leda Bassit
  • , Janet Figueroa
  • , Anna Wood
  • , Traci Leong
  • , Anuradha Rao
  • , Beverly Rogers
  • , Robert Jerris
  • , Sunita Park
  • , Mark Gonzalez
  • , Jennifer Frediani
  • , Claudia Morris
  • Joshua Levy, Nils Schoof, Maud Mavigner, John Roback, Kristen Herzegh, Natia Saakadze, Jess Ingersoll, Narayana Cheedarla, Andrew Neish, Bradley Hanberry, Christopher Porter, Annette Esper, Russell Kempker, Paulina Rebolledo, Pamela McGuinness, Frederick Balagadde, Rebecca Gore, Ainat Koren, Nira Pollock, Eugene Rogers, Karl Simin, Nathaniel Hafer, Mary Ann Picard, Chiara Ghezzi, David McManus, Bryan Buchholz, Christina Rostad, Viviana Claveria, Thanuja Ramachandra, Yun F. Wang, Cadeidre Washington, Cheryl Stone, Mark Griffiths, Ray Schinazi, Ann Chahroudi, Miriam Vos, Oliver Brand, Greg Martin, Wilbur Lam
*Corresponding author for this work
  • Emory University
  • Georgia Institute of Technology
  • University of Massachusetts Lowell
  • Boston Children's Hospital
  • University of Massachusetts Medical School
  • Children's Healthcare of Atlanta

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the 'RADxSM Tech Test Verification Core' and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to preserve lives and facilitate the safe return to work and school. Focal points included: laboratory and clinical device evaluation of the limit of viral detection, sensitivity, and specificity of devices in controlled and community settings; regulatory expertise to provide focused attention to barriers to device approval and distribution; usability testing from the perspective of patients and those using the tests to identify and overcome device limitations, and engineering assessment to evaluate robustness of design including human factors, manufacturability, and scalability.

Original languageEnglish
Article number9418534
Pages (from-to)142-151
Number of pages10
JournalIEEE Open Journal of Engineering in Medicine and Biology
Volume2
DOIs
Publication statusPublished - 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19
  • Device Testing
  • RADx

Fingerprint

Dive into the research topics of 'The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change'. Together they form a unique fingerprint.

Cite this